Haojie Jin

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 14

Top Topics

Top Venues

Nature reviews. Drug discovery

Cancer discovery

Cancer communications (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Matheus Henrique Dias, Anoek Friskes, Siying Wang, João M Fernandes Neto, Frank van Gemert, Soufiane M C Mourragui, Chrysa Papagianni, Hendrik J Kuiken, Sara Mainardi, Daniel Alvarez-Villanueva, Cor Lieftink, Ben Morris, Anna Dekker, Emma van Dijk, Lieke H S Wilms, Marcelo Santos da Silva, Robin A Jansen, Antonio Mulero-Sanchez, Elke Malzer, August Vidal Bel, Cristina Santos, Ramón Salazar, Rosangela A M Wailemann, Thompson E P Torres, Giulia De Conti, Jonne A Raaijmakers, Petur Snaebjornsson, Sheng-Xian Yuan, Wenxin Qin, John S Kovach, Hugo Aguirre Armelin, Hein Te Riele, Alexander van Oudernaarden, Haojie Jin, Roderick L Beijersbergen, Alberto Villanueva, René H Medema, René Bernards
Paradoxical Activation of Oncogenic Signaling as a Cancer Treatment Strategy. Cancer discovery 14 (7) (2024)
Matheus Henrique Dias, Anoek Friskes, Siying Wang, João M Fernandes Neto, Frank van Gemert, Soufiane M C Mourragui, Chrysa Papagianni, Hendrik J Kuiken, Sara Mainardi, Daniel Alvarez-Villanueva, Cor Lieftink, Ben Morris, Anna Dekker, Emma van Dijk, Lieke H S Wilms, Marcelo Santos da Silva, Robin A Jansen, Antonio Mulero-Sanchez, Elke Malzer, August Vidal Bel, Cristina Santos, Ramón Salazar, Rosangela A M Wailemann, Thompson E P Torres, Giulia De Conti, Jonne A Raaijmakers, Petur Snaebjornsson, Sheng-Xian Yuan, Wenxin Qin, John S Kovach, Hugo Aguirre Armelin, Hein Te Riele, Alexander van Oudernaarden, Haojie Jin, Roderick L Beijersbergen, Alberto Villanueva, René H Medema, René Bernards
Paradoxical Activation of Oncogenic Signaling as a Cancer Treatment Strategy. Cancer discovery 14 (7) (2024)
Matheus Henrique Dias, Anoek Friskes, Siying Wang, João M Fernandes Neto, Frank van Gemert, Soufiane M C Mourragui, Chrysa Papagianni, Hendrik J Kuiken, Sara Mainardi, Daniel Alvarez-Villanueva, Cor Lieftink, Ben Morris, Anna Dekker, Emma van Dijk, Lieke H S Wilms, Marcelo Santos da Silva, Robin A Jansen, Antonio Mulero-Sanchez, Elke Malzer, August Vidal Bel, Cristina Santos, Ramón Salazar, Rosangela A M Wailemann, Thompson E P Torres, Giulia De Conti, Jonne A Raaijmakers, Petur Snaebjornsson, Sheng-Xian Yuan, Wenxin Qin, John S Kovach, Hugo Aguirre Armelin, Hein Te Riele, Alexander van Oudernaarden, Haojie Jin, Roderick L Beijersbergen, Alberto Villanueva, René H Medema, René Bernards
Paradoxical activation of oncogenic signaling as a cancer treatment strategy. Cancer discovery (2024)
Matheus Henrique Dias, Anoek Friskes, Siying Wang, João M Fernandes Neto, Frank van Gemert, Soufiane M C Mourragui, Chrysa Papagianni, Hendrik J Kuiken, Sara Mainardi, Daniel Alvarez-Villanueva, Cor Lieftink, Ben Morris, Anna Dekker, Emma van Dijk, Lieke H S Wilms, Marcelo Santos da Silva, Robin A Jansen, Antonio Mulero-Sanchez, Elke Malzer, August Vidal Bel, Cristina Santos, Ramón Salazar, Rosangela A M Wailemann, Thompson E P Torres, Giulia De Conti, Jonne A Raaijmakers, Petur Snaebjornsson, Sheng-Xian Yuan, Wenxin Qin, John S Kovach, Hugo Aguirre Armelin, Hein Te Riele, Alexander van Oudernaarden, Haojie Jin, Roderick L Beijersbergen, Alberto Villanueva, René H Medema, René Bernards
Paradoxical Activation of Oncogenic Signaling as a Cancer Treatment Strategy. Cancer discovery 14 (7) (2024)
Yu Chen, Wu Yang, Jiaojiao Zheng, René Bernards, Haojie Jin
Drug-drug synthetic lethality to combat cancer: From bench to bedside. Clinical and translational medicine 13 (5) (2023)
Zhen Sun, Siying Wang, Xiaoxiao Sun, Yaoping Shi, Haojie Jin
COVID-19 has causal effects on cancer risk? Something we might ignore. Journal of medical virology 95 (8) (2023)
Yaoping Shi, Donghua Shi, Jiachang Chi, Dan Cui, Xiaoyin Tang, Yan Lin, Siying Wang, Zonghai Li, Haojie Jin, Bo Zhai
Combined local therapy and CAR-GPC3 T-cell therapy in advanced hepatocellular carcinoma: a proof-of-concept treatment strategy. Cancer communications (London, England) (2023)
Haojie Jin, Liqin Wang, René Bernards
Rational combinations of targeted cancer therapies: background, advances and challenges. Nature reviews. Drug discovery 22 (3) (2022)
Haojie Jin, Liqin Wang, René Bernards
Rational combinations of targeted cancer therapies: background, advances and challenges. Nature reviews. Drug discovery (2022)
Haojie Jin, Liqin Wang, René Bernards
Rational combinations of targeted cancer therapies: background, advances and challenges. Nature reviews. Drug discovery 22 (3) (2022)
Haojie Jin, Liqin Wang, René Bernards
Rational combinations of targeted cancer therapies: background, advances and challenges. Nature reviews. Drug discovery 22 (3) (2022)
Haojie Jin, Liqin Wang, René Bernards
Rational combinations of targeted cancer therapies: background, advances and challenges. Nature reviews. Drug discovery (2022)
Haojie Jin, Siying Wang, Esther A Zaal, Cun Wang, Haiqiu Wu, Astrid Bosma, Fleur Jochems, Nikita Isima, Guangzhi Jin, Cor Lieftink, Roderick Beijersbergen, Celia R Berkers, Wenxin Qin, René Bernards
A powerful drug combination strategy targeting glutamine addiction for the treatment of human liver cancer. eLife 9 (2020)
Haiqiu Wu, Cun Wang, Jiaxin Sun, Luyan Sun, Jiaxun Wan, Siying Wang, Dishui Gu, Chengtao Yu, Chen Yang, Jia He, Zihao Zhang, Yuanyuan Lv, Hui Wang, Ming Yao, Wenxin Qin, Changchun Wang, Haojie Jin
Self-Assembled and Self-Monitored Sorafenib/Indocyanine Green Nanodrug with Synergistic Antitumor Activity Mediated by Hyperthermia and Reactive Oxygen Species-Induced Apoptosis. ACS applied materials & interfaces 11 (47) (2019)